Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
Latest Information Update: 12 May 2014
At a glance
- Drugs DWP 431 (Primary)
- Indications Alveolar bone loss
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
Most Recent Events
- 12 May 2014 New trial record